Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | AXSM | KRYS | ||
| Company | Halozyme Therapeutic | Axsome Thera | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 72.81 | 176.00 | 295.00 | ||
| High | 73.76 | 176.00 | 295.00 | ||
| Low | 70.75 | 176.00 | 279.56 | ||
| Latest | 71.43 | 174.28 | 282.14 | ||
| Change | -0.39 | +0.14 | +0.13 | ||
| % Change | -0.54% | +0.08% | +0.05% | ||
| Volume | 2,172,600 | 708 | 288,700 | ||
| 20-Day Average Volume | 1,784,520 | 788,920 | 308,830 | ||
| Previous Close | 72.96 | 174.14 | 291.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 69.96 | 165.22 | 255.00 | ||
| 20-Day Raw Stochastic | 65.12% | 78.20% | 78.27% | ||
| 20-Day Relative Strength | 56.30 | 63.64 | 71.54 | ||
| Weighted Alpha | +32.47 | +97.12 | +116.02 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.43% since 01/08/26 | +3.91% since 01/09/26 | +13.30% since 01/08/26 | ||
| Low | 70.75 on 01/15/26 | 170.06 on 01/12/26 | 252.92 on 01/09/26 | ||
| High | 74.08 on 01/14/26 | 179.45 on 01/12/26 | 295.98 on 01/14/26 | ||
| 1-Month | |||||
| %Chg | +13.19% since 12/15/25 | +19.83% since 12/16/25 | +16.06% since 12/15/25 | ||
| Low | 62.98 on 12/16/25 | 145.71 on 12/17/25 | 231.68 on 12/18/25 | ||
| High | 75.59 on 01/07/26 | 184.40 on 12/31/25 | 295.98 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | +8.23% since 10/15/25 | +40.80% since 10/16/25 | +46.13% since 10/15/25 | ||
| Low | 61.22 on 12/11/25 | 123.50 on 11/03/25 | 183.03 on 10/23/25 | ||
| High | 75.59 on 01/07/26 | 184.40 on 12/31/25 | 295.98 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +26.89% since 07/15/25 | +58.10% since 07/16/25 | +90.90% since 07/15/25 | ||
| Low | 55.64 on 07/21/25 | 96.09 on 08/04/25 | 130.50 on 08/04/25 | ||
| High | 79.50 on 09/23/25 | 184.40 on 12/31/25 | 295.98 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,445,816 | 8,778,918 | 8,177,723 | ||
| Shares Outstanding, K | 117,597 | 50,413 | 28,998 | ||
| Annual Sales | 1,015,320,000 | 385,690,000 | 290,520,000 | ||
| Annual Net Income | 444,090,000 | -287,220,000 | 89,160,000 | ||
| Last Quarter Sales | 354,260,000 | 170,990,000 | 97,800,000 | ||
| Last Quarter Net Income | 175,230,000 | -47,230,000 | 79,370,000 | ||
| 60-Month Beta | 0.94 | 0.44 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.72 on 11/03/25 | -0.94 on 11/03/25 | 2.66 on 11/03/25 | ||
| Latest Earnings Date | 02/17/26 | 02/17/26 | 02/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 13.71 | 0.00 | 43.75 | ||